VVT Med Inc. (TSXV:VVTM)

Canada flag Canada · Delayed Price · Currency is CAD
0.260
-0.010 (-3.70%)
At close: Mar 5, 2026
-43.48%
Market Cap 18.74M
Revenue (ttm) 156.00K
Net Income (ttm) -4.38M
Shares Out 66.93M
EPS (ttm) -0.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 17,920
Open 0.260
Previous Close 0.270
Day's Range 0.260 - 0.260
52-Week Range 0.150 - 0.560
Beta n/a
RSI 46.59
Earnings Date May 21, 2026

About VVT Med

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P – 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VVTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.